Phthalazinone Pyrazole Enhances the Hepatic Functions of Human Embryonic Stem Cell-Derived Hepatocyte-Like Cells via Suppression of the Epithelial-Mesenchymal Transition

Young Jun Choi, Hyemin Kim, Ji Woo Kim, Chang Woo Song, Dae-Sung Kim, Seokjoo Yoon, Han Jin Park

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

During liver development, nonpolarized hepatic progenitor cells differentiate into mature hepatocytes with distinct polarity. This polarity is essential for maintaining the intrinsic properties of hepatocytes. The balance between the epithelial-mesenchymal transition (EMT) and mesenchymal-epithelial transition (MET) plays a decisive role in differentiation of polarized hepatocytes. In this study, we found that phthalazinone pyrazole (PP), a selective inhibitor of Aurora-A kinase (Aurora-A), suppressed the EMT during the differentiation of hepatocyte-like cells (HLCs) from human embryonic stem cells. The differentiated HLCs treated with PP at the hepatoblast stage showed enhanced hepatic morphology and functions, particularly with regard to the expression of drug metabolizing enzymes. Moreover, we found that these effects were mediated though suppression of the AKT pathway, which is involved in induction of the EMT, and upregulation of hepatocyte nuclear factor 4α expression rather than Aurora-A inhibition. In conclusion, these findings provided insights into the regulatory role of the EMT on in vitro hepatic maturation, suggesting that inhibition of the EMT may drive transformation of hepatoblast cells into mature and polarized HLCs.

Original languageEnglish
Pages (from-to)438-450
Number of pages13
JournalStem Cell Reviews and Reports
Volume14
Issue number3
DOIs
Publication statusPublished - 2018 Jun 1

Fingerprint

Epithelial-Mesenchymal Transition
Hepatocytes
Liver
Hepatocyte Nuclear Factor 4
Aurora Kinase A
Human Embryonic Stem Cells
pyrazole
Up-Regulation
Stem Cells
Enzymes
Pharmaceutical Preparations

Keywords

  • Epithelial-mesenchymal transition
  • Hepatocyte-like cells
  • Mesenchymal-epithelial transition
  • Phthalazinone pyrazole
  • Polarity

ASJC Scopus subject areas

  • Cell Biology
  • Cancer Research

Cite this

Phthalazinone Pyrazole Enhances the Hepatic Functions of Human Embryonic Stem Cell-Derived Hepatocyte-Like Cells via Suppression of the Epithelial-Mesenchymal Transition. / Choi, Young Jun; Kim, Hyemin; Kim, Ji Woo; Song, Chang Woo; Kim, Dae-Sung; Yoon, Seokjoo; Park, Han Jin.

In: Stem Cell Reviews and Reports, Vol. 14, No. 3, 01.06.2018, p. 438-450.

Research output: Contribution to journalArticle

@article{ec363eccfe044a39ba3a596a0edceb6a,
title = "Phthalazinone Pyrazole Enhances the Hepatic Functions of Human Embryonic Stem Cell-Derived Hepatocyte-Like Cells via Suppression of the Epithelial-Mesenchymal Transition",
abstract = "During liver development, nonpolarized hepatic progenitor cells differentiate into mature hepatocytes with distinct polarity. This polarity is essential for maintaining the intrinsic properties of hepatocytes. The balance between the epithelial-mesenchymal transition (EMT) and mesenchymal-epithelial transition (MET) plays a decisive role in differentiation of polarized hepatocytes. In this study, we found that phthalazinone pyrazole (PP), a selective inhibitor of Aurora-A kinase (Aurora-A), suppressed the EMT during the differentiation of hepatocyte-like cells (HLCs) from human embryonic stem cells. The differentiated HLCs treated with PP at the hepatoblast stage showed enhanced hepatic morphology and functions, particularly with regard to the expression of drug metabolizing enzymes. Moreover, we found that these effects were mediated though suppression of the AKT pathway, which is involved in induction of the EMT, and upregulation of hepatocyte nuclear factor 4α expression rather than Aurora-A inhibition. In conclusion, these findings provided insights into the regulatory role of the EMT on in vitro hepatic maturation, suggesting that inhibition of the EMT may drive transformation of hepatoblast cells into mature and polarized HLCs.",
keywords = "Epithelial-mesenchymal transition, Hepatocyte-like cells, Mesenchymal-epithelial transition, Phthalazinone pyrazole, Polarity",
author = "Choi, {Young Jun} and Hyemin Kim and Kim, {Ji Woo} and Song, {Chang Woo} and Dae-Sung Kim and Seokjoo Yoon and Park, {Han Jin}",
year = "2018",
month = "6",
day = "1",
doi = "10.1007/s12015-017-9795-4",
language = "English",
volume = "14",
pages = "438--450",
journal = "Stem Cell Reviews",
issn = "1550-8943",
publisher = "Humana Press",
number = "3",

}

TY - JOUR

T1 - Phthalazinone Pyrazole Enhances the Hepatic Functions of Human Embryonic Stem Cell-Derived Hepatocyte-Like Cells via Suppression of the Epithelial-Mesenchymal Transition

AU - Choi, Young Jun

AU - Kim, Hyemin

AU - Kim, Ji Woo

AU - Song, Chang Woo

AU - Kim, Dae-Sung

AU - Yoon, Seokjoo

AU - Park, Han Jin

PY - 2018/6/1

Y1 - 2018/6/1

N2 - During liver development, nonpolarized hepatic progenitor cells differentiate into mature hepatocytes with distinct polarity. This polarity is essential for maintaining the intrinsic properties of hepatocytes. The balance between the epithelial-mesenchymal transition (EMT) and mesenchymal-epithelial transition (MET) plays a decisive role in differentiation of polarized hepatocytes. In this study, we found that phthalazinone pyrazole (PP), a selective inhibitor of Aurora-A kinase (Aurora-A), suppressed the EMT during the differentiation of hepatocyte-like cells (HLCs) from human embryonic stem cells. The differentiated HLCs treated with PP at the hepatoblast stage showed enhanced hepatic morphology and functions, particularly with regard to the expression of drug metabolizing enzymes. Moreover, we found that these effects were mediated though suppression of the AKT pathway, which is involved in induction of the EMT, and upregulation of hepatocyte nuclear factor 4α expression rather than Aurora-A inhibition. In conclusion, these findings provided insights into the regulatory role of the EMT on in vitro hepatic maturation, suggesting that inhibition of the EMT may drive transformation of hepatoblast cells into mature and polarized HLCs.

AB - During liver development, nonpolarized hepatic progenitor cells differentiate into mature hepatocytes with distinct polarity. This polarity is essential for maintaining the intrinsic properties of hepatocytes. The balance between the epithelial-mesenchymal transition (EMT) and mesenchymal-epithelial transition (MET) plays a decisive role in differentiation of polarized hepatocytes. In this study, we found that phthalazinone pyrazole (PP), a selective inhibitor of Aurora-A kinase (Aurora-A), suppressed the EMT during the differentiation of hepatocyte-like cells (HLCs) from human embryonic stem cells. The differentiated HLCs treated with PP at the hepatoblast stage showed enhanced hepatic morphology and functions, particularly with regard to the expression of drug metabolizing enzymes. Moreover, we found that these effects were mediated though suppression of the AKT pathway, which is involved in induction of the EMT, and upregulation of hepatocyte nuclear factor 4α expression rather than Aurora-A inhibition. In conclusion, these findings provided insights into the regulatory role of the EMT on in vitro hepatic maturation, suggesting that inhibition of the EMT may drive transformation of hepatoblast cells into mature and polarized HLCs.

KW - Epithelial-mesenchymal transition

KW - Hepatocyte-like cells

KW - Mesenchymal-epithelial transition

KW - Phthalazinone pyrazole

KW - Polarity

UR - http://www.scopus.com/inward/record.url?scp=85038005758&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85038005758&partnerID=8YFLogxK

U2 - 10.1007/s12015-017-9795-4

DO - 10.1007/s12015-017-9795-4

M3 - Article

C2 - 29238913

AN - SCOPUS:85038005758

VL - 14

SP - 438

EP - 450

JO - Stem Cell Reviews

JF - Stem Cell Reviews

SN - 1550-8943

IS - 3

ER -